Onkure Therapeutics, Inc.
OKUR
Revenue
0.00
0.000.00%
-Assets
86.07M
▼-13.81M▼-13.83%
3 Months ChangeLiabilities
7.90M
▼-1.33M▼-14.40%
3 Months ChangeFree Cash Flow
-14.02M
▼-3.39M▼-31.82%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-08
Form 8-K
ID: 0001193125-24-234487
2024-10-02
Form 8-K
ID: 0001193125-24-231281
2024-09-20
Form 8-K
ID: 0001193125-24-222429
2024-09-13
Form 8-K
ID: 0001193125-24-218879
2024-08-13
Form 10-Q
ID: 0000950170-24-096411
2024-08-13
Form 8-K
ID: 0000950170-24-096127
2024-05-13
Form 8-K
ID: 0001193125-24-136785
2024-05-07
Form 10-Q
ID: 0000950170-24-054452
2024-05-07
Form 8-K
ID: 0000950170-24-054442
2024-03-28
Form 8-K
ID: 0000950170-24-038003